Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

The poster is titled Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tutors ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...

Intel Corporation today announced that it will report fourth-quarter and full-year 2024 financial results on Thursday, Jan. 30, 2025, promptly after close of market. Intel will then hold an earnings ...

Ascent Strategy Group, the first public relations agency dedicated to powering healthcare's digital transformation, is recognized by Modern Healthcare's Best in Business for setting a standard of ...

Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...

Californian oncology-focused biotech Avenzo Therapeutics and China-based Duality Biotherapeutics (DualityBio) have entered ...